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BOOK REVIEWS
Hyperthermia in cancer therapy. F. KRISTIAN
STORM, (Editor) USA, G.K. Hall, xiii+566 pp,
1983 £58.50.
Hyperthermia is becoming of increasing interest as
a method of treating cancer. A considerable
amount of experimental work has been carried out
over the past 10 to 15 years, and more recently an
increasing number of centres are treating patients
with hyperthermia. It does, however, very much
remain an experimental method at this time and
only to be used under investigational circumstances.
Apart from the specialised literature presented in
journals, there have been numerous reviews of the
subject but until now, no comprehensive books.
However this has been corrected recently by the
publication of two books by different authors. This
particular volume is edited by one of the clinicians
who has worked in the field, and contains
contributions by many authors distinguished in
their original research.
The book itself attempts to be very
comprehensive but suffers from some surprising
omissions and also is now slightly dated in some
aspects. Not surprisingly because of the nature of
the subject, the experimental sections are much
stronger than the clinical ones. The clinical
presentation is also somewhat biased by the
personal preference of the editor, who is a
proponent of a clinical technique which has not
been accepted by others.
The complexity of the subject is well illustrated
by the range of topics discussed. Those concerned
with the biological aspects cover the relevant topics
very adequately, if perhaps with a rather arbitrary
degree of detail imposed by the different authors.
Thus a chapter on thermosensitivity in neoplastic
cells in vitro is only seven pages in length, whilst a
similar one on tissues in vivo is 78 pages long. The
excellent chapter on thermotolerance is marred by a
failure to discuss the induction of heat shock
proteins. It is also very surprising that there is no
chapter in which the important subject of the
interaction of heat and drugs is specifically
discussed.
The sections on physical methods are important
because it is the technology at present which is
limiting adequate clinical use. There are very useful
chapters on theoretical aspects of both heat
induction and temperature measurement. As
already stated, the application of those methods to
clinical results is probably the least well
documented part of the book. This is perhaps no
fault of the authors, and it correctly expresses the
current state of the art. One final note of criticism
about methodology might be made, in that there is
no mention of a technique employing an annular
array of microwave sources which is perhaps the
most favoured commercially available equipment in
the United States. This technique has attracted
much interest in the USA and one would have
thought that some discussion ofit should have been
presented in this book.
This review may sound rather critical of the
book. It is always easy to find faults but on balance
this is a volume which can be recommended to all
who are interested in hyperthermia. For those who
are active in the field it will present useful reviews
in subjects not directly within their expertise. For
those who are not involved but wish to learn about
it, it provides a useful source of reading. It is
pe'rhaps too long to be read from cover to cover by
such persons but would be useful for reference.
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Adult T cell leukaemia and related diseases. M.
HANAOKA, K. TAKATSUKI, & M. SHIMOYAMA
(Editors) Japan, Japan Scientific Societies Press &
Plenum Press, viii+243 pp, 1982, $45.
Haematological diseases now recognised as
neoplastic proliferation of T lymphocytes received
eponymous titles earlier this century following
clinical descriptions by Steinberg and Sezary. In
1976, Dr. Takatsuki's group in Kyoto proposed the
title "adult T-cell leukaemia" for a new disease
entity with more or less distinctive morphological,
clinical and epidemiological features. Subsequently,
the blurred borderline between leukaemic and
lymphomatous cases prompted a revision of the
title, which is now conveniently referred to as Adult
T cell-leukaemia lymphoma (ATLL). Such cases
occur sporadically throughout the world but their
especially high prevalence in Southern Japan, now
confirmed by the use of immunological markers,
has evoked an enormous interest. The role of a
recently defined human retrovirus (ATLV) in
leukaemogenesis has been intensively studied and
there now seems little doubt that this virus is widely
distributed throughout those parts of Southern
Japan, and also in the Carribean, where the disease